Skip to main content
Equibles

MetLife Investment Management, LLC

Position in AVXL — Anavex Life Sciences Corp.

CIK 1529735 Whippany, NJ
Back to AVXL Full portfolio

Position in AVXL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$133,713
+$24,943 QoQ
Shares Held
51,627
+45.7% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 179 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AVXL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. AVXL ranks #221 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in AVXL

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $133,713 51,627
2026-03-31 $108,770 35,430
2025-12-31 $127,163 35,720
2025-09-30 $396,984 44,605
2025-03-31 $389,042 45,343
2024-12-31 $495,940 46,177
2024-09-30 $229,250 40,361
2024-06-30 $170,323 40,361
2024-03-31 $143,873 28,266
2023-12-31 $337,478 36,249
2023-09-30 $237,430 36,249
2023-06-30 $294,704 36,249
2023-03-31 $310,653 36,249
2022-12-31 $335,665 36,249
2022-09-30 $374,089 36,249
2022-06-30 $337,296 33,696
2022-03-31 $454,423 36,915
2021-12-31 $403,883 23,292
2021-09-30 $418,091 23,292
2021-06-30 $532,455 23,292
2021-03-31 $348,215 23,292
2020-12-31 $43,740 8,100
2020-09-30 $21,471 4,719
2020-06-30 $126,719 25,756